Empirical Study of Transfecting Early Growth Response Gene‐1 DNA Enzyme to Prevent Intimal Hyperlasia of Autogenous Vein Graft in Rats
Shu-Qing Wang,Cheng-Wei Liu,Da-Ming Lv,Yu-Ming Kang,Shu-Qiu Wang,Xiao-Dong Wei,Wen-Bo Qin
DOI: https://doi.org/10.1096/fasebj.23.1_supplement.774.2
2009-01-01
The FASEB Journal
Abstract:To detect the inhibitory action of early growth response gene‐1 DNA enzyme (EDRz) to vascular smooth muscle cell (VSMC) proliferation and intimal hyperplasia, with liposome as carrer, and to confirm the effect of gene therapy on stenosis and occlusion after vein transplantation. Construct early growth response gene‐1 DNA enzyme, autogenous vein graft model was established in 90 Sprage‐Dawley rats. After surgery, rats were randomly divided into at 1, 2, 6, 24 hours, 3, 7, 14, 28, 42 days groups. At 1h after graft, early growth response gene‐1 DNA enzyme was mainly located in media, adventitia and partial endothelial cells of vein graft. From 2h to 24h it was located in media of vein graft, while it was mainly located intimal of vein graft at 7d. There were not early growth response gene‐1 DNA enzyme in vein grafts at the late phase. We found that Egr‐1 protein mainly located in the medial VSMCs, monocytes and endothelium cells of vein graft at the early phase, and at the late phase no Egr‐1 protein was found in medial and neointimal VSMCs. The positive cells rate: at 2h, 6h, 24h, 3d is 15.3±4.2%, 9.7±2.4%, 6.4±1.8%, 2.3±0.2%. Conclusions: Early growth response gene‐1 DNA enzyme can reduce the expression of Egr‐1 in autogenous vein graft, it can effectively restrain VSMC proliferation and intimal hyperplasia, and then prevent vascular stenosis and occlusion after vein graft.